# Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study

Study · id `cardio:ct-nct07121088` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07121088](<https://clinicaltrials.gov/study/NCT07121088>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07121088

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 3666 participants.

## Technical summary

Registry record NCT07121088. Non-randomized; no masking; primary purpose treatment. Start 2025-08-31 (anticipated); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 3666 participants (planned count; ClinicalTrials.gov record NCT07121088, source copy `cardio:ctgov-nct07121088-2025-08-13`, retrieved 2026-10-26)
- Planned start: 2025-08-31 (anticipated) (ClinicalTrials.gov record NCT07121088, source copy `cardio:ctgov-nct07121088-2025-08-13`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT07121088, source copy `cardio:ctgov-nct07121088-2025-08-13`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07121088, source copy `cardio:ctgov-nct07121088-2025-08-13`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07121088-2025-08-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study
- Acronym: TIDES
- Condition: Ischemic Cerebral Infarction
- Condition: Diabetes Mellitus
- Intervention (Drug): (Intensive treatment) Chuanzhi Tongluo Capsules
- Intervention (Other): Standard Treatment (Guideline-Based)
- Intervention (Drug): (Sequential treatment) Chuanzhi Tongluo Capsules
- Intervention (Drug): TCM Syndrome Differentiation Decoction
- Lead sponsor: Guangzhou University of Traditional Chinese Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Guangzhou University of Traditional Chinese Medicine (`cardio:org-guangzhou-university-of-traditional-chinese-medicine`)

## Provenance

Content hash: 6f0b88e50b85dfbc61a8c9ded5cb3ce57d653aa2a2f8862c2c1181a7f73c7afd
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
